TipRanks
Go Ultimate55% OFF

Medipal Holdings (7459) Price & Analysis

7459 Stock Chart & Stats

¥3,441.00¥67.00(1.99%)
At close: 4:00 PM EDT
JPY 2,750JPY 3,000JPY 3,2503 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 3,371.00 - JPY 3,441.00
52-Week Range
JPY 2,456.50 - JPY 3,449.00
Previous Close
JPY 3,374.00
Volume
650.70K
Average Volume (3M)
460.02K
Market Cap
JPY 624.24B
Enterprise Value
JPY 432.01B
Total Cash (Recent Filing)
JPY 289.92B
Total Debt (Recent Filing)
JPY 43.23B
Price to Earnings (P/E)
15.1
Beta
0.36
Next Earnings
Feb 03, 2027
EPS Estimate
N/A
Dividend Yield
2.27%

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth

Multi-year revenue growth indicates resilient demand across the distribution business and supports the durability of its healthcare and consumer-goods customer base. Continued top-line expansion can reinforce scale advantages, sustain network relevance, and provide a foundation for dependable operating performance.

Very Conservative Balance Sheet

Minimal leverage materially reduces financial risk and leaves the company less exposed to refinancing pressure or rising interest costs. The conservative balance sheet also preserves flexibility to maintain operations, support distribution capabilities, and pursue growth while protecting long-term stability.

Generally Positive Cash Generation

Recurring positive free cash flow demonstrates that the distribution model can convert operations into internally generated funds across multiple periods. This supports ongoing investment, shareholder distributions, and balance-sheet resilience, even though the timing of cash generation is not completely consistent.

Bears Say

Structurally Thin Margins

Very thin profitability leaves limited room to absorb operating pressure, cost increases, or execution setbacks before earnings are affected. The low-margin structure also means that sustained revenue growth may translate into only modest absolute profit expansion unless efficiency or operating leverage improves.

Variable Cash Flow

Uneven cash conversion makes the company’s internally funded resources less predictable from year to year. The stated influence of working-capital swings can complicate investment and capital-allocation planning, requiring continued monitoring even when reported earnings and free cash flow are generally positive.

Operating Profit Volatility

A reduction in EBIT while revenue increased suggests that incremental sales are not consistently producing stronger operating returns. This limits confidence in near-term margin expansion and indicates that earnings remain sensitive to the economics of the scale-driven distribution model.

Medipal Holdings News

7459 FAQ

What was Medipal Holdings’s price range in the past 12 months?
Medipal Holdings lowest stock price was ¥2456.50 and its highest was ¥3449.00 in the past 12 months.
What is Medipal Holdings’s market cap?
Medipal Holdings’s market cap is ¥624.24B.
When is Medipal Holdings’s upcoming earnings report date?
Medipal Holdings’s upcoming earnings report date is Oct 29, 2026 which is 3 days ago.
How were Medipal Holdings’s earnings last quarter?
Medipal Holdings released its earnings results on Aug 05, 2026. The company reported ¥66.67 earnings per share for the quarter, beating the consensus estimate of ¥46.17 by ¥20.5.
Is Medipal Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Medipal Holdings pay dividends?
Medipal Holdings pays a Semiannually dividend of ¥44 which represents an annual dividend yield of 2.27%. See more information on Medipal Holdings dividends here
What is Medipal Holdings’s EPS estimate?
Medipal Holdings’s EPS estimate is 70.03.
How many shares outstanding does Medipal Holdings have?
Medipal Holdings has 215,975,040 shares outstanding.
What happened to Medipal Holdings’s price movement after its last earnings report?
Medipal Holdings reported an EPS of ¥66.67 in its last earnings report, beating expectations of ¥46.17. Following the earnings report the stock price went up 0.686%.
Which hedge fund is a major shareholder of Medipal Holdings?
Currently, no hedge funds are holding shares in JP:7459
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology